findmyKOL

Robert Lee, MD

Basic profile

Interventional Cardiology

ORCIDNone on fileNPI
RegionLos Alamitos, CA · WestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNot yet indexedOnline presenceNot yet checkedPayments2021 onwardNIH funding2012–2023Why? →

Robert Lee is a Cardiology physician. ClinicalTrials.gov lists 5 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials
38companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
2NIH grants · 2012–2023

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5300 Katella Ave
Los Alamitos, CA 907202808

Telephone

562-430-7533

Registry record last updated 21 Jul 2022.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    74.5%
    Beta blocker23%
    Metoprolol Succinate61%Metoprolol Tartrate18%Carvedilol9%Sotalol9%Propranolol Hcl3%
    Part D<11 patients
    Statin13.8%
    Rosuvastatin Calcium52%Atorvastatin Calcium48%
    Part D79 patients

    + 15 more classes in this area

  • Blood & clotting

    24.7%
    Factor Xa inhibitor19.1%
    Eliquis70%Xarelto30%
    Part D123 patients
    P2Y12 inhibitor4.3%
    Clopidogrel93%Brilinta8%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    0.8%
    Potassium supplement0.8%
    Potassium Chloride100%
    Part D14 patients
Where care is delivered (Part B)31.8% facility · 68.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 20122023 per NIH RePORTER. The latest:

2 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”